 | • レポートコード：MRC2012B0162 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、犬関節炎治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。犬関節炎治療の種類別市場規模（非ステロイド性抗炎症薬、オピオイド、幹細胞治療）、用途別市場規模（獣医病院・診療所、小売薬局、ドラッグストア、Eコマース）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Elanco (Eli Lilly and Company)、VetStem Biopharma、Vetoquinol S.A.、Boehringer Ingelheim、Norbrook Laboratories Limited、Zoetis Inc、Aratana Therapeutics Inc、Bayer AG、Dechra Pharmaceuticals Plc、 ・地域別グローバル市場分析 2015年-2020年 ・犬関節炎治療の北米市場（アメリカ、カナダ、メキシコ） ・犬関節炎治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・犬関節炎治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・犬関節炎治療の南米市場（ブラジル、アルゼンチン） ・犬関節炎治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：非ステロイド性抗炎症薬、オピオイド、幹細胞治療 ・用途別分析：獣医病院・診療所、小売薬局、ドラッグストア、Eコマース ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Canine Arthritis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Canine Arthritis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Canine Arthritis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Canine Arthritis Treatment market has been segmented into:
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Stem Cell Therapy
By Application, Canine Arthritis Treatment has been segmented into:
Veterinary Hospitals and Clinics
Retail Pharmacies
Drug Stores
E-commerce
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Canine Arthritis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Canine Arthritis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Canine Arthritis Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Canine Arthritis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Canine Arthritis Treatment Market Share Analysis
Canine Arthritis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Canine Arthritis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Canine Arthritis Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Canine Arthritis Treatment are:
Elanco (Eli Lilly and Company)
VetStem Biopharma
Vetoquinol S.A.
Boehringer Ingelheim
Norbrook Laboratories Limited
Zoetis Inc
Aratana Therapeutics Inc
Bayer AG
Dechra Pharmaceuticals Plc
Table of Contents
1 Canine Arthritis Treatment Market Overview
1.1 Product Overview and Scope of Canine Arthritis Treatment
1.2 Classification of Canine Arthritis Treatment by Type
1.2.1 Global Canine Arthritis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Canine Arthritis Treatment Revenue Market Share by Type in 2019
1.2.3 Non-Steroidal Anti-Inflammatory Drugs
1.2.4 Opioids
1.2.5 Stem Cell Therapy
1.3 Global Canine Arthritis Treatment Market by Application
1.3.1 Overview: Global Canine Arthritis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Veterinary Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 E-commerce
1.4 Global Canine Arthritis Treatment Market by Regions
1.4.1 Global Canine Arthritis Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Canine Arthritis Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Canine Arthritis Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Canine Arthritis Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Canine Arthritis Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Canine Arthritis Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Canine Arthritis Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Elanco (Eli Lilly and Company)
2.1.1 Elanco (Eli Lilly and Company) Details
2.1.2 Elanco (Eli Lilly and Company) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Elanco (Eli Lilly and Company) SWOT Analysis
2.1.4 Elanco (Eli Lilly and Company) Product and Services
2.1.5 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 VetStem Biopharma
2.2.1 VetStem Biopharma Details
2.2.2 VetStem Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 VetStem Biopharma SWOT Analysis
2.2.4 VetStem Biopharma Product and Services
2.2.5 VetStem Biopharma Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Vetoquinol S.A.
2.3.1 Vetoquinol S.A. Details
2.3.2 Vetoquinol S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Vetoquinol S.A. SWOT Analysis
2.3.4 Vetoquinol S.A. Product and Services
2.3.5 Vetoquinol S.A. Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim SWOT Analysis
2.4.4 Boehringer Ingelheim Product and Services
2.4.5 Boehringer Ingelheim Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Norbrook Laboratories Limited
2.5.1 Norbrook Laboratories Limited Details
2.5.2 Norbrook Laboratories Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Norbrook Laboratories Limited SWOT Analysis
2.5.4 Norbrook Laboratories Limited Product and Services
2.5.5 Norbrook Laboratories Limited Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Zoetis Inc
2.6.1 Zoetis Inc Details
2.6.2 Zoetis Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Zoetis Inc SWOT Analysis
2.6.4 Zoetis Inc Product and Services
2.6.5 Zoetis Inc Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Aratana Therapeutics Inc
2.7.1 Aratana Therapeutics Inc Details
2.7.2 Aratana Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Aratana Therapeutics Inc SWOT Analysis
2.7.4 Aratana Therapeutics Inc Product and Services
2.7.5 Aratana Therapeutics Inc Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer AG
2.8.1 Bayer AG Details
2.8.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer AG SWOT Analysis
2.8.4 Bayer AG Product and Services
2.8.5 Bayer AG Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Dechra Pharmaceuticals Plc
2.9.1 Dechra Pharmaceuticals Plc Details
2.9.2 Dechra Pharmaceuticals Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Dechra Pharmaceuticals Plc SWOT Analysis
2.9.4 Dechra Pharmaceuticals Plc Product and Services
2.9.5 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Canine Arthritis Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Canine Arthritis Treatment Players Market Share
3.2.2 Top 10 Canine Arthritis Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Canine Arthritis Treatment Revenue and Market Share by Regions
4.2 North America Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
5 North America Canine Arthritis Treatment Revenue by Countries
5.1 North America Canine Arthritis Treatment Revenue by Countries (2015-2020)
5.2 USA Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
6 Europe Canine Arthritis Treatment Revenue by Countries
6.1 Europe Canine Arthritis Treatment Revenue by Countries (2015-2020)
6.2 Germany Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
6.4 France Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Canine Arthritis Treatment Revenue by Countries
7.1 Asia-Pacific Canine Arthritis Treatment Revenue by Countries (2015-2020)
7.2 China Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
7.5 India Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
8 South America Canine Arthritis Treatment Revenue by Countries
8.1 South America Canine Arthritis Treatment Revenue by Countries (2015-2020)
8.2 Brazil Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Canine Arthritis Treatment by Countries
9.1 Middle East & Africa Canine Arthritis Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Canine Arthritis Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Canine Arthritis Treatment Market Forecast by Type (2019-2024)
10.3 Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2015-2025)
10.4 Opioids Revenue Growth Rate (2015-2025)
10.5 Stem Cell Therapy Revenue Growth Rate (2015-2025)
11 Global Canine Arthritis Treatment Market Segment by Application
11.1 Global Canine Arthritis Treatment Revenue Market Share by Application (2015-2020)
11.2 Canine Arthritis Treatment Market Forecast by Application (2019-2024)
11.3 Veterinary Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Drug Stores Revenue Growth (2015-2020)
11.6 E-commerce Revenue Growth (2015-2020)
12 Global Canine Arthritis Treatment Market Size Forecast (2021-2025)
12.1 Global Canine Arthritis Treatment Market Size Forecast (2021-2025)
12.2 Global Canine Arthritis Treatment Market Forecast by Regions (2021-2025)
12.3 North America Canine Arthritis Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Canine Arthritis Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Canine Arthritis Treatment Revenue Market Forecast (2021-2025)
12.6 South America Canine Arthritis Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Canine Arthritis Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Canine Arthritis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Canine Arthritis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Canine Arthritis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Canine Arthritis Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Elanco (Eli Lilly and Company) Corporate Information, Location and Competitors
Table 6. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Major Business
Table 7. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Elanco (Eli Lilly and Company) SWOT Analysis
Table 9. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product and Solutions
Table 10. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. VetStem Biopharma Corporate Information, Location and Competitors
Table 12. VetStem Biopharma Canine Arthritis Treatment Major Business
Table 13. VetStem Biopharma Canine Arthritis Treatment Total Revenue (USD Million) (2018-2019)
Table 14. VetStem Biopharma SWOT Analysis
Table 15. VetStem Biopharma Canine Arthritis Treatment Product and Solutions
Table 16. VetStem Biopharma Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Vetoquinol S.A. Corporate Information, Location and Competitors
Table 18. Vetoquinol S.A. Canine Arthritis Treatment Major Business
Table 19. Vetoquinol S.A. Canine Arthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Vetoquinol S.A. SWOT Analysis
Table 21. Vetoquinol S.A. Canine Arthritis Treatment Product and Solutions
Table 22. Vetoquinol S.A. Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 24. Boehringer Ingelheim Canine Arthritis Treatment Major Business
Table 25. Boehringer Ingelheim Canine Arthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Boehringer Ingelheim SWOT Analysis
Table 27. Boehringer Ingelheim Canine Arthritis Treatment Product and Solutions
Table 28. Boehringer Ingelheim Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Norbrook Laboratories Limited Corporate Information, Location and Competitors
Table 30. Norbrook Laboratories Limited Canine Arthritis Treatment Major Business
Table 31. Norbrook Laboratories Limited Canine Arthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Norbrook Laboratories Limited SWOT Analysis
Table 33. Norbrook Laboratories Limited Canine Arthritis Treatment Product and Solutions
Table 34. Norbrook Laboratories Limited Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Zoetis Inc Corporate Information, Location and Competitors
Table 36. Zoetis Inc Canine Arthritis Treatment Major Business
Table 37. Zoetis Inc Canine Arthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Zoetis Inc SWOT Analysis
Table 39. Zoetis Inc Canine Arthritis Treatment Product and Solutions
Table 40. Zoetis Inc Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Aratana Therapeutics Inc Corporate Information, Location and Competitors
Table 42. Aratana Therapeutics Inc Canine Arthritis Treatment Major Business
Table 43. Aratana Therapeutics Inc Canine Arthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Aratana Therapeutics Inc SWOT Analysis
Table 45. Aratana Therapeutics Inc Canine Arthritis Treatment Product and Solutions
Table 46. Aratana Therapeutics Inc Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bayer AG Corporate Information, Location and Competitors
Table 48. Bayer AG Canine Arthritis Treatment Major Business
Table 49. Bayer AG Canine Arthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Bayer AG SWOT Analysis
Table 51. Bayer AG Canine Arthritis Treatment Product and Solutions
Table 52. Bayer AG Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Dechra Pharmaceuticals Plc Corporate Information, Location and Competitors
Table 54. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Major Business
Table 55. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Dechra Pharmaceuticals Plc SWOT Analysis
Table 57. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product and Solutions
Table 58. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Canine Arthritis Treatment Revenue (Million USD) by Players (2015-2020)
Table 60. Global Canine Arthritis Treatment Revenue Share by Players (2015-2020)
Table 61. Global Canine Arthritis Treatment Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Canine Arthritis Treatment Revenue Market Share by Regions (2015-2020)
Table 63. North America Canine Arthritis Treatment Revenue by Countries (2015-2020)
Table 64. North America Canine Arthritis Treatment Revenue Market Share by Countries (2015-2020)
Table 65. Europe Canine Arthritis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Canine Arthritis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Canine Arthritis Treatment Revenue by Countries (2015-2020)
Table 68. South America Canine Arthritis Treatment Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Canine Arthritis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Canine Arthritis Treatment Revenue Market Share by Countries (2015-2020)
Table 71. Global Canine Arthritis Treatment Revenue (Million USD) by Type (2015-2020)
Table 72. Global Canine Arthritis Treatment Revenue Share by Type (2015-2020)
Table 73. Global Canine Arthritis Treatment Revenue Forecast by Type (2021-2025)
Table 74. Global Canine Arthritis Treatment Revenue by Application (2015-2020)
Table 75. Global Canine Arthritis Treatment Revenue Share by Application (2015-2020)
Table 76. Global Canine Arthritis Treatment Revenue Forecast by Application (2021-2025)
Table 77. Global Canine Arthritis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Canine Arthritis Treatment Picture
Figure 2. Global Canine Arthritis Treatment Revenue Market Share by Type in 2019
Figure 3. Non-Steroidal Anti-Inflammatory Drugs Picture
Figure 4. Opioids Picture
Figure 5. Stem Cell Therapy Picture
Figure 6. Canine Arthritis Treatment Revenue Market Share by Application in 2019
Figure 7. Veterinary Hospitals and Clinics Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Drug Stores Picture
Figure 10. E-commerce Picture
Figure 11. Global Canine Arthritis Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Canine Arthritis Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Canine Arthritis Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Canine Arthritis Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Canine Arthritis Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Canine Arthritis Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Canine Arthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Canine Arthritis Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Canine Arthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Canine Arthritis Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Canine Arthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Canine Arthritis Treatment Revenue Market Share by Countries in 2019
Figure 44. China Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Canine Arthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Canine Arthritis Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Canine Arthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Canine Arthritis Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Canine Arthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Canine Arthritis Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Canine Arthritis Treatment Revenue Share by Type in 2019
Figure 61. Global Canine Arthritis Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2015-2020)
Figure 63. Global Opioids Revenue Growth Rate (2015-2020)
Figure 64. Global Stem Cell Therapy Revenue Growth Rate (2015-2020)
Figure 65. Global Canine Arthritis Treatment Revenue Share by Application (2015-2020)
Figure 66. Global Canine Arthritis Treatment Revenue Share by Application in 2019
Figure 67. Global Canine Arthritis Treatment Market Share Forecast by Application (2021-2025)
Figure 68. Global Veterinary Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Drug Stores Revenue Growth Rate (2015-2020)
Figure 71. Global E-commerce Revenue Growth Rate (2015-2020)
Figure 72. Global Canine Arthritis Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Canine Arthritis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Canine Arthritis Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Canine Arthritis Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Canine Arthritis Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Canine Arthritis Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Canine Arthritis Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Canine Arthritis Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
犬アトピー性皮膚炎治療の世界市場（～2026年） Canine atopic dermatitis is a problem that is related to the skin, which when exposed to the allergens results in allergic symptoms. Market Analysis and Insights: Global Canine Atopic Dermatitis Treatment Market The global Canine Atopic Dermatitis Treatment market size is projected to reach US$ XX m…- 関節リウマチ治療の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…
- 犬幹細胞治療の世界市場（～2026年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- 乾癬性関節炎治療の世界市場（～2026年） Market Analysis and Insights: Global Psoriatic Arthritis Treatment Market The global Psoriatic Arthritis Treatment market size is projected to reach US$ 8155.4 million by 2026, from US$ 7679.9 million in 2020, at a CAGR of 5.7%% during 2021-2026. Global Psoriatic Arthritis Treatment Scope and Market…
- 全身性特発性若年性関節炎治療の世界市場（～2026年） Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market The global Systemic Idiopathic Juvenile Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Systemic Idiopath…